Alberto Lopez-Pastorini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alberto Lopez-Pastorini has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Aris Koryllos
Universität Witten Herdecke, Kliniken der Stadt Köln, Merheim
4 shared publications Erich Stoelben
Department of Thoracic Surgery, Cologne-Merheim Hospital, Witten/Herdecke University Hospital, Cologne, Germany; Faculty of Medicine, University of Cologne, Cologne, Germany
3 shared publications- Erich Stoelben
Department of Thoracic Surgery, University Witten/Herdecke , Witten, Germany
3 shared publications Antonia von Bargen
Faculty of Medicine, Witten/Herdecke University, Witten, Germany
2 shared publicationsAris Koryllos
Department of Thoracic Surgery, Cologne-Merheim Hospital, Witten/Herdecke University Hospital, Cologne, Germany; Faculty of Medicine, Witten/Herdecke University, Witten, Germany
2 shared publicationsDennis Faltenberg
Faculty of Medicine, Witten/Herdecke University, Witten, Germany
2 shared publications
Latest Publications
- Open Access
- 14 March 2025
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 15 (3) , 113
Non-Small Cell Lung Cancer Patients with Skip-N2 Metastases Have Similar Survival to N1 Patients—A Multicenter Analysis
Introduction: Nodal involvement is one of the most important prognostic factors in NSCLC. Skip-N2 metastasis (N0N2), which is N2 metastasis in the absence of N1 metastasis, occurs in approximately 20–30% of patients. According to the International Association for the Study of Lung Cancer, N1 and N0N2 patients may have comparable long-term survival, considering their similar tumor stages. However, this conclusion remains controversial. Therefore, we carried out this multicenter study to examine the long-term survival and disease-free interval (DFI) of N0N2- and N1 patients. Methods: One-, three-, and five-year survival rates were measured. Kaplan–Meier curves and a Cox proportional hazards model assessed survival and were used to identify prognostic factors for overall survival. Results: Between January 2010 and December 2020, 273 N0N2 and N1 patients were included in our analysis. Of those patients, 77 showed N0N2 and 196 N1. Baseline characteristics did not differ significantly between groups. Between N0N2 and N1 patients, there were no significant differences in one- (p = 0.67), three- (p = 0.20), and five-year (p = 0.27) survival. Furthermore, DFI did not differ between groups (p = 0.45). Conclusions: Our findings indicate that N0N2 patients have a prognosis comparable to that of patients with N1 disease. These results indicate that patients with N0N2 have a similar prognosis to N1 patients. N2-NSCLC is heterogeneous and would benefit from a more precise subdivision and differential treatment in the upcoming UICC 9 classification. The following question remains: are we overtreating N0N2 patients or undertreating N1 patients?
- 14 March 2025
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 15 (3) , 113
Open AccessNon-Small Cell Lung Cancer Patients with Skip-N2 Metastases Have Similar Survival to N1 Patients—A Multicenter Analysis
Introduction: Nodal involvement is one of the most important prognostic factors in NSCLC. Skip-N2 metastasis (N0N2), which is N2 metastasis in the absence of N1 metastasis, occurs in approximately 20–30% of patients. According to the International Association for the Study of Lung Cancer, N1 and N0N2 patients may have comparable long-term survival, considering their similar tumor stages. However, this conclusion remains controversial. Therefore, we carried out this multicenter study to examine the long-term survival and disease-free interval (DFI) of N0N2- and N1 patients. Methods: One-, three-, and five-year survival rates were measured. Kaplan–Meier curves and a Cox proportional hazards model assessed survival and were used to identify prognostic factors for overall survival. Results: Between January 2010 and December 2020, 273 N0N2 and N1 patients were included in our analysis. Of those patients, 77 showed N0N2 and 196 N1. Baseline characteristics did not differ significantly between groups. Between N0N2 and N1 patients, there were no significant differences in one- (p = 0.67), three- (p = 0.20), and five-year (p = 0.27) survival. Furthermore, DFI did not differ between groups (p = 0.45). Conclusions: Our findings indicate that N0N2 patients have a prognosis comparable to that of patients with N1 disease. These results indicate that patients with N0N2 have a similar prognosis to N1 patients. N2-NSCLC is heterogeneous and would benefit from a more precise subdivision and differential treatment in the upcoming UICC 9 classification. The following question remains: are we overtreating N0N2 patients or undertreating N1 patients?
- 10 December 2024
- Published by Elsevier in Journal of Surgical Research
- Vol. 305, 85-92
The Prognostic Value of Preoperative C-Reactive Protein Levels in Resected Early-Stage Lung Cancer
- 10 December 2024
- Published by Elsevier in Journal of Surgical Research
- Vol. 305, 85-92
The Prognostic Value of Preoperative C-Reactive Protein Levels in Resected Early-Stage Lung Cancer
- 29 August 2024
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 73 (04) , 317-324
Staging of Early-Stage Lung Cancer without Routine PET in Candidates for Segmentectomy
Introduction We aimed to investigate the accuracy of clinical staging without the routine use of positron emission tomography/computed tomography (PET/CT) in patients with cIA1 and cIA2 non-small-cell lung cancer (NSCLC) scheduled for segmentectomy. Methods A total of 305 consecutive segmentectomies were retrospectively analyzed. Overall survival was calculated using the Kaplan–Meier method. Logistic regression was performed to investigate factors independently associated with pathologic upstaging. Results The Union for International Cancer Control (UICC) upstaging was found in 86 patients (28%). Upstaged patients had longer operative times (146 ± 46 vs. 131 ± 44 minutes, p = 0.009), a higher number of lymph node resection (17 ± 10 vs. 13 ± 8, p = 0.001), and a higher rate of L1 involvement (34 vs. 16%, p < 0.001) than nonupstaged patients. N1 was found in 10 patients (3%) and N2 in 13 patients (4%). Nodal positive patients had longer operation times (154 ± 50 vs. 133 ± 44 minutes, p = 0.031) and higher rates of R1 (9 vs. 1%, p = 0.006) and L1 (39 vs. 20%, p < 0.026) than patients without nodal involvement. The 3- and 5-year overall survival rates for nonupstaged and upstaged patients were 85 and 67% and 67 and 54%, respectively (p = 0.040). In logistic regression, L1 involvement (odds ratio [OR]: 2.394, p = 0.005) and the number of dissected lymph nodes (OR: 1.037, p = 0.016) were independently associated with upstaging. Patients who received PET as part of clinical staging did not have a significantly lower nodal upstaging. Conclusion Selective use of PET/CT based on the results of CT may be a viable option for patients with proven or suspected NSCLC up to 2 cm in size.
- 29 August 2024
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 73 (04) , 317-324
Staging of Early-Stage Lung Cancer without Routine PET in Candidates for Segmentectomy
Introduction We aimed to investigate the accuracy of clinical staging without the routine use of positron emission tomography/computed tomography (PET/CT) in patients with cIA1 and cIA2 non-small-cell lung cancer (NSCLC) scheduled for segmentectomy. Methods A total of 305 consecutive segmentectomies were retrospectively analyzed. Overall survival was calculated using the Kaplan–Meier method. Logistic regression was performed to investigate factors independently associated with pathologic upstaging. Results The Union for International Cancer Control (UICC) upstaging was found in 86 patients (28%). Upstaged patients had longer operative times (146 ± 46 vs. 131 ± 44 minutes, p = 0.009), a higher number of lymph node resection (17 ± 10 vs. 13 ± 8, p = 0.001), and a higher rate of L1 involvement (34 vs. 16%, p < 0.001) than nonupstaged patients. N1 was found in 10 patients (3%) and N2 in 13 patients (4%). Nodal positive patients had longer operation times (154 ± 50 vs. 133 ± 44 minutes, p = 0.031) and higher rates of R1 (9 vs. 1%, p = 0.006) and L1 (39 vs. 20%, p < 0.026) than patients without nodal involvement. The 3- and 5-year overall survival rates for nonupstaged and upstaged patients were 85 and 67% and 67 and 54%, respectively (p = 0.040). In logistic regression, L1 involvement (odds ratio [OR]: 2.394, p = 0.005) and the number of dissected lymph nodes (OR: 1.037, p = 0.016) were independently associated with upstaging. Patients who received PET as part of clinical staging did not have a significantly lower nodal upstaging. Conclusion Selective use of PET/CT based on the results of CT may be a viable option for patients with proven or suspected NSCLC up to 2 cm in size.
- 15 February 2024
- Published by Georg Thieme Verlag KG in Zentralblatt fur Chirurgie
- Vol. 149 (03) , 298-307
Resektionen der Trachealbifurkation
Zusammenfassung: Die Bifurkationsresektion wird in der Literatur übereinstimmend als einer der anspruchsvollsten thoraxchirurgischen Eingriffe beschrieben. Unter diesem Begriff werden verschiedene Eingriffe zusammengefasst, die abhängig von der zugrunde liegenden Erkrankung und ihrer Ausdehnung unterschiedliche Resektionsformen und Rekonstruktionstechniken erfordern. Aus chirurgischer Sicht sind vor allem die engen anatomischen Verhältnisse und die Technik der Rekonstruktion der zentralen Atemwege herausfordernd. Ein komplexes Atemwegsmanagement und eine aufwendige postoperative Nachsorge zeigen jedoch, dass diese Eingriffe über die chirurgische Expertise hinaus, die Leistung eines multidisziplinären Teams darstellen. Dieser Artikel widmet sich den wichtigsten prä-, intra- und postoperativen Aspekten dieser Eingriffe.
- 15 February 2024
- Published by Georg Thieme Verlag KG in Zentralblatt fur Chirurgie
- Vol. 149 (03) , 298-307
Resektionen der Trachealbifurkation
Zusammenfassung: Die Bifurkationsresektion wird in der Literatur übereinstimmend als einer der anspruchsvollsten thoraxchirurgischen Eingriffe beschrieben. Unter diesem Begriff werden verschiedene Eingriffe zusammengefasst, die abhängig von der zugrunde liegenden Erkrankung und ihrer Ausdehnung unterschiedliche Resektionsformen und Rekonstruktionstechniken erfordern. Aus chirurgischer Sicht sind vor allem die engen anatomischen Verhältnisse und die Technik der Rekonstruktion der zentralen Atemwege herausfordernd. Ein komplexes Atemwegsmanagement und eine aufwendige postoperative Nachsorge zeigen jedoch, dass diese Eingriffe über die chirurgische Expertise hinaus, die Leistung eines multidisziplinären Teams darstellen. Dieser Artikel widmet sich den wichtigsten prä-, intra- und postoperativen Aspekten dieser Eingriffe.
- 1 February 2023
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 63 (2)
Patients’ satisfaction with local and general anaesthesia for video-assisted thoracoscopic surgery—results of the first randomized controlled trial PASSAT
The objective of this single-centre, open, randomized control trial was to compare the patients’ satisfaction with local anaesthesia (LA) or general anaesthesia (GA) for video-assisted thoracoscopy. Patients with indication for video-assisted thoracoscopy pleural management, mediastinal biopsies or lung wedge resections were randomized for LA or GA. LA was administered along with no or mild sedation and no airway devices maintaining spontaneous breathing, and GA was administered along with double-lumen tube and one-lung ventilation. The primary end point was anaesthesia-related satisfaction according to psychometrically validated questionnaires. Patients not willing to be randomized could attend based on their desired anaesthesia, forming the preference arm. Fifty patients were allocated to LA and 57 patients to GA. Age, smoking habits and lung function were similarly distributed in both groups. There was no significant difference between the 2 groups with regard to patient satisfaction with anaesthesiology care (median 2.75 vs 2.75, P = 0.74), general perioperative care (2.50 vs 2.50, P = 0.57), recovery after surgery (2.00 vs 2.00, P = 0.16, 3-point Likert scales). Surgeons and anaesthesiologists alike were less satisfied with feasibility (P < 0.01 each) with patients in the LA group. Operation time, postoperative pain scales, delirium and complication rate were similar in both groups. LA patients had a significantly shorter stay in hospital (mean 3.9 vs 6.0 days, P < 0.01). Of 18 patients in the preference arm, 17 chose LA, resulting in similar satisfaction. Patients were equally satisfied with both types of anaesthesia, regardless of whether the type of anaesthesia was randomized or deliberately chosen. LA is as safe as GA but correlated with shorter length of stay. Almost all patients of the preference arm chose LA. Considering the benefits of LA, it should be offered to patients as an equivalent alternative to GA whenever medically appropriate and feasible.
- 1 February 2023
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 63 (2)
Patients’ satisfaction with local and general anaesthesia for video-assisted thoracoscopic surgery—results of the first randomized controlled trial PASSAT
The objective of this single-centre, open, randomized control trial was to compare the patients’ satisfaction with local anaesthesia (LA) or general anaesthesia (GA) for video-assisted thoracoscopy. Patients with indication for video-assisted thoracoscopy pleural management, mediastinal biopsies or lung wedge resections were randomized for LA or GA. LA was administered along with no or mild sedation and no airway devices maintaining spontaneous breathing, and GA was administered along with double-lumen tube and one-lung ventilation. The primary end point was anaesthesia-related satisfaction according to psychometrically validated questionnaires. Patients not willing to be randomized could attend based on their desired anaesthesia, forming the preference arm. Fifty patients were allocated to LA and 57 patients to GA. Age, smoking habits and lung function were similarly distributed in both groups. There was no significant difference between the 2 groups with regard to patient satisfaction with anaesthesiology care (median 2.75 vs 2.75, P = 0.74), general perioperative care (2.50 vs 2.50, P = 0.57), recovery after surgery (2.00 vs 2.00, P = 0.16, 3-point Likert scales). Surgeons and anaesthesiologists alike were less satisfied with feasibility (P < 0.01 each) with patients in the LA group. Operation time, postoperative pain scales, delirium and complication rate were similar in both groups. LA patients had a significantly shorter stay in hospital (mean 3.9 vs 6.0 days, P < 0.01). Of 18 patients in the preference arm, 17 chose LA, resulting in similar satisfaction. Patients were equally satisfied with both types of anaesthesia, regardless of whether the type of anaesthesia was randomized or deliberately chosen. LA is as safe as GA but correlated with shorter length of stay. Almost all patients of the preference arm chose LA. Considering the benefits of LA, it should be offered to patients as an equivalent alternative to GA whenever medically appropriate and feasible.
- 9 August 2019
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 68 (04) , 341-351
Anterior Chest Wall Reconstruction Using Polypropylene Mesh: A Retrospective Study
Background Anterior chest wall resection for oncological purposes is usually combined with a form of reconstruction. Most surgeons are convinced that ventrally located defects more than 4 to 5 cm require adequate reconstruction to minimize the risk of lung herniation and respiratory distress through paradox motion. We describe our in-house results of ventral chest wall reconstruction using polypropylene mesh without the use of metallic or biological implants regardless of the extent of chest wall resection. Methods Patient selection involved ventral chest wall resection and reconstruction by polypropylene mesh for all indications such as primary tumors, metastasis, or infiltration by lung cancer from January 2008 to December 2016. Primary end point was the difference between both sides. Secondary end points were postoperative complications such as infection, surgical revision, and pulmonary complications. Results Forty-five cases of isolated anterior reconstruction could be identified. In 34 cases, postoperative computed tomography scan of the thorax was available. Fifteen males and 19 females with a median age of 70.5 years were operated. The evaluation of maximum hemithorax diameter between operated and nonoperated sides was documented in centimeters, and the difference was documented in percentage. The mean percentage difference was 11.1% (minimum: 0.3, maximum: 44.4). In one case, wound infection with positive culture could not be treated conservatively and required operative revision and removal of the polypropylene mesh. Conclusion Polypropylene mesh, though not rigid, can safely be used for anterior chest wall reconstruction.
- 9 August 2019
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 68 (04) , 341-351
Anterior Chest Wall Reconstruction Using Polypropylene Mesh: A Retrospective Study
Background Anterior chest wall resection for oncological purposes is usually combined with a form of reconstruction. Most surgeons are convinced that ventrally located defects more than 4 to 5 cm require adequate reconstruction to minimize the risk of lung herniation and respiratory distress through paradox motion. We describe our in-house results of ventral chest wall reconstruction using polypropylene mesh without the use of metallic or biological implants regardless of the extent of chest wall resection. Methods Patient selection involved ventral chest wall resection and reconstruction by polypropylene mesh for all indications such as primary tumors, metastasis, or infiltration by lung cancer from January 2008 to December 2016. Primary end point was the difference between both sides. Secondary end points were postoperative complications such as infection, surgical revision, and pulmonary complications. Results Forty-five cases of isolated anterior reconstruction could be identified. In 34 cases, postoperative computed tomography scan of the thorax was available. Fifteen males and 19 females with a median age of 70.5 years were operated. The evaluation of maximum hemithorax diameter between operated and nonoperated sides was documented in centimeters, and the difference was documented in percentage. The mean percentage difference was 11.1% (minimum: 0.3, maximum: 44.4). In one case, wound infection with positive culture could not be treated conservatively and required operative revision and removal of the polypropylene mesh. Conclusion Polypropylene mesh, though not rigid, can safely be used for anterior chest wall reconstruction.
- Open Access
- 1 March 2019
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 11 (S3) , S283-S285
Editorial on “Trans-inferior-pulmonary-ligament VATS basal segmentectomy: application of single-direction strategy in segmentectomy of left S9+10”
Editorial on “Trans-inferior-pulmonary-ligament VATS basal segmentectomy: application of single-direction strategy in segmentectomy of left S9+10”
- 1 March 2019
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 11 (S3) , S283-S285
Open AccessEditorial on “Trans-inferior-pulmonary-ligament VATS basal segmentectomy: application of single-direction strategy in segmentectomy of left S9+10”
Editorial on “Trans-inferior-pulmonary-ligament VATS basal segmentectomy: application of single-direction strategy in segmentectomy of left S9+10”
- 1 July 2017
- Published by Elsevier in Lung Cancer
- Vol. 109, 68-73
The impact of preoperative elevated serum C-reactive protein on postoperative morbidity and mortality after anatomic resection for lung cancer
- 1 July 2017
- Published by Elsevier in Lung Cancer
- Vol. 109, 68-73
The impact of preoperative elevated serum C-reactive protein on postoperative morbidity and mortality after anatomic resection for lung cancer
- Open Access
- 17 September 2015
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 9 (1) , 1-4
Spontaneous regression of non-small cell lung cancer after biopsy of a mediastinal lymph node metastasis: a case report
Spontaneous regression of cancer is defined as a complete or partial, temporary or permanent disappearance of tumor in the absence of specific therapy. With only a few cases reported, spontaneous regression is extremely rare in primary lung cancer. Regarding spontaneous regression in lung cancer, recent investigations revealed the role of immunological mechanisms, thus indicating potential treatment options by specific immunotherapy in the future. A 76-year-old Caucasian man with progressive dyspnea presented to our hospital. A computed tomography scan revealed a tumor mass in the upper lobe of his right lung and enlarged mediastinal lymph nodes. A biopsy of a paratracheal lymph node by mediastinoscopy disclosed metastatic lung cancer. By immunohistochemical findings the tumor was classified as large cell carcinoma. Diagnosed with clinical stage IIIA non-small cell lung cancer, a neoadjuvant therapy concept was indicated. However, before starting chemoradiation, a computed tomography scan showed a regression of both the tumor mass in the upper lobe of his right lung and the mediastinal lymphadenopathy. As a repeated computed tomography scan showed further regression, we agreed with our patient to perform routine follow-up instead of starting therapy. To date, no relapse has been reported. Given the circumstances that regression started after the biopsy and involved both the tumor in the upper lobe of his right lung and the mediastinal lymph node metastases, an immune response is a reasonable explanation for the observed spontaneous regression in this case.
- 17 September 2015
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 9 (1) , 1-4
Open AccessSpontaneous regression of non-small cell lung cancer after biopsy of a mediastinal lymph node metastasis: a case report
Spontaneous regression of cancer is defined as a complete or partial, temporary or permanent disappearance of tumor in the absence of specific therapy. With only a few cases reported, spontaneous regression is extremely rare in primary lung cancer. Regarding spontaneous regression in lung cancer, recent investigations revealed the role of immunological mechanisms, thus indicating potential treatment options by specific immunotherapy in the future. A 76-year-old Caucasian man with progressive dyspnea presented to our hospital. A computed tomography scan revealed a tumor mass in the upper lobe of his right lung and enlarged mediastinal lymph nodes. A biopsy of a paratracheal lymph node by mediastinoscopy disclosed metastatic lung cancer. By immunohistochemical findings the tumor was classified as large cell carcinoma. Diagnosed with clinical stage IIIA non-small cell lung cancer, a neoadjuvant therapy concept was indicated. However, before starting chemoradiation, a computed tomography scan showed a regression of both the tumor mass in the upper lobe of his right lung and the mediastinal lymphadenopathy. As a repeated computed tomography scan showed further regression, we agreed with our patient to perform routine follow-up instead of starting therapy. To date, no relapse has been reported. Given the circumstances that regression started after the biopsy and involved both the tumor in the upper lobe of his right lung and the mediastinal lymph node metastases, an immune response is a reasonable explanation for the observed spontaneous regression in this case.
- 21 April 2015
- Published by Georg Thieme Verlag KG in Pneumologie
- Vol. 69 (06) , 335-340
Reduktion Tracheostoma-assoziierter Trachealstenosen durch chirurgischen Stomaverschluss
Hintergrund: Die häufigste Langzeitkomplikation nach einer Tracheotomie ist die benigne Trachealstenose, welche mit einer Inzidenz von bis zu 20 % beschrieben ist. Typischerweise tritt die Stenose nach Dekanülierung im Rahmen der sekundären Wundheilung auf. In dieser Studie wurde überprüft, ob der chirurgische Verschluss des Tracheostomas die Stenoserate reduziert. Methode: Anhand der klinischen Datenbank unserer Abteilung wurde eine retrospektive Analyse von 401 chirurgischen Tracheostomata durchgeführt. Erfasst wurden die Indikation zur Tracheotomie, der klinische Verlauf nach Stomaanlage sowie auftretende Komplikationen. Ergebnisse: 155 Patienten konnten erfolgreich dekanüliert werden. Bei 92 der dekanülierten Patienten wurde das Tracheostoma chirurgisch verschlossen, bei 63 erfolgte der Verschluss spontan durch Wundheilung. Nach Dekanülierung kam es bei 3 % (n = 3) der chirurgisch verschlossenen und bei 22 % (n = 14) der spontan durch sekundäre Wundheilung verschlossenen Tracheostomata zu symptomatischen Trachealstenosen (p < 0,001). Schlussfolgerung: Bei einem Verschluss des Tracheostomas durch sekundäre Wundheilung wurden häufig symptomatische Trachealstenosen beobachtet. Dagegen konnte in der Patientengruppe, welche einen chirurgischen Verschluss des Tracheostomas erhielt, das Auftreten symptomatischer Trachealstenosen signifikant reduziert werden. Background: The most common long-term complication of tracheotomy is the benign stenosis of the trachea, which is described for up to 20 % of the cases. Typically, the stenosis occurs after decannulation in the context of secondary wound healing. This study examined whether the closure of the tracheostomy by surgical procedure reduces stenosis. Method: With the help of our clinical database a retrospective analysis of 401 surgical tracheotomies was performed. Variables that were recorded were the indication for tracheotomy, the clinical course and complications occurred. Results: 155 patients were successfully decannulated. In 92 of these patients the tracheostomy was closed by a surgical procedure, in 63 cases the closure occurred spontaneously by wound healing. After decannulation 3 % (n = 3) of the surgically closed and 22 % (n = 14) of the spontaneously closed tracheostomies developed a symptomatic tracheal stenosis (p < 0.001). Conclusion: Secondary wound healing of the tracheostomy often leads to symptomatic tracheal stenosis. The incidence of symptomatic tracheal stenosis was significantly reduced applying closure of the tracheostomy by surgical procedure. * Die Ergebnisse dieser Studie wurden auf der 23. Jahrestagung der Deutschen Gesellschaft für Thoraxchirurgie (DGT) in Osnabrück am 3. 10. 2014 im Rahmen eines Vortrages vorgestellt.
- 21 April 2015
- Published by Georg Thieme Verlag KG in Pneumologie
- Vol. 69 (06) , 335-340
Reduktion Tracheostoma-assoziierter Trachealstenosen durch chirurgischen Stomaverschluss
Hintergrund: Die häufigste Langzeitkomplikation nach einer Tracheotomie ist die benigne Trachealstenose, welche mit einer Inzidenz von bis zu 20 % beschrieben ist. Typischerweise tritt die Stenose nach Dekanülierung im Rahmen der sekundären Wundheilung auf. In dieser Studie wurde überprüft, ob der chirurgische Verschluss des Tracheostomas die Stenoserate reduziert. Methode: Anhand der klinischen Datenbank unserer Abteilung wurde eine retrospektive Analyse von 401 chirurgischen Tracheostomata durchgeführt. Erfasst wurden die Indikation zur Tracheotomie, der klinische Verlauf nach Stomaanlage sowie auftretende Komplikationen. Ergebnisse: 155 Patienten konnten erfolgreich dekanüliert werden. Bei 92 der dekanülierten Patienten wurde das Tracheostoma chirurgisch verschlossen, bei 63 erfolgte der Verschluss spontan durch Wundheilung. Nach Dekanülierung kam es bei 3 % (n = 3) der chirurgisch verschlossenen und bei 22 % (n = 14) der spontan durch sekundäre Wundheilung verschlossenen Tracheostomata zu symptomatischen Trachealstenosen (p < 0,001). Schlussfolgerung: Bei einem Verschluss des Tracheostomas durch sekundäre Wundheilung wurden häufig symptomatische Trachealstenosen beobachtet. Dagegen konnte in der Patientengruppe, welche einen chirurgischen Verschluss des Tracheostomas erhielt, das Auftreten symptomatischer Trachealstenosen signifikant reduziert werden. Background: The most common long-term complication of tracheotomy is the benign stenosis of the trachea, which is described for up to 20 % of the cases. Typically, the stenosis occurs after decannulation in the context of secondary wound healing. This study examined whether the closure of the tracheostomy by surgical procedure reduces stenosis. Method: With the help of our clinical database a retrospective analysis of 401 surgical tracheotomies was performed. Variables that were recorded were the indication for tracheotomy, the clinical course and complications occurred. Results: 155 patients were successfully decannulated. In 92 of these patients the tracheostomy was closed by a surgical procedure, in 63 cases the closure occurred spontaneously by wound healing. After decannulation 3 % (n = 3) of the surgically closed and 22 % (n = 14) of the spontaneously closed tracheostomies developed a symptomatic tracheal stenosis (p < 0.001). Conclusion: Secondary wound healing of the tracheostomy often leads to symptomatic tracheal stenosis. The incidence of symptomatic tracheal stenosis was significantly reduced applying closure of the tracheostomy by surgical procedure. * Die Ergebnisse dieser Studie wurden auf der 23. Jahrestagung der Deutschen Gesellschaft für Thoraxchirurgie (DGT) in Osnabrück am 3. 10. 2014 im Rahmen eines Vortrages vorgestellt.